Healthcare | November 11, 2021
Curadev Pharma partners with CMC Vellore for dengue research
The company will provide the technical and financial resources to support the study
The company will provide the technical and financial resources to support the study
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
Subscribe To Our Newsletter & Stay Updated
